ELFHIGH SIGNALOPPORTUNITY10-K

ELF delivered exceptional financial performance with 270% revenue growth and 549% net income increase, while simultaneously signaling strategic evolution through brand portfolio changes and potential acquisitions.

The dramatic financial improvement suggests ELF has achieved significant scale and operational leverage, transforming from modest profitability to substantial earnings generation. The language changes indicate strategic repositioning away from skin care focus and potential major M&A activity with the rhode acquisition reference, suggesting management is actively reshaping the business model during this high-growth phase.

Comparing 2025-05-29 vs 2024-05-23View on EDGAR →
FINANCIAL ANALYSIS

ELF demonstrated remarkable financial transformation with revenue surging 270% to $1.3B and net income exploding 549% to $112.1M, indicating exceptional operational leverage as gross profit grew proportionally with sales while SG&A expenses increased only 35%. The company strengthened its balance sheet with 37% higher cash reserves and 18% equity growth, though debt increased 59% likely to fund expansion, while current liabilities declined 41% suggesting improved working capital management. Overall, the financial picture signals a company that has achieved significant scale and profitability inflection, generating substantial cash flow ($134M operating cash flow, up 88%) to fund continued growth investments.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+549.4%
$17.3M$112.1M

Net income grew 549.4% — bottom-line growth signals improving overall business health.

Revenue
P&L
+269.7%
$355.3M$1.3B

Strong top-line growth of 269.7% — accelerating demand or successful expansion into new markets.

Gross Profit
P&L
+269.4%
$253.3M$935.7M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Capital Expenditure
Cash Flow
+113.9%
$8.7M$18.5M

Capital expenditure jumped 113.9% — major investment cycle underway; assess returns on deployment.

Operating Cash Flow
Cash Flow
+88.1%
$71.2M$133.8M

Operating cash flow surged 88.1% — exceptional cash generation, highest quality earnings signal.

Total Debt
Balance Sheet
+58.6%
$161.8M$256.7M

Debt increased 58.6% — substantial leverage increase; assess whether deployed for growth or covering losses.

Current Liabilities
Balance Sheet
-40.8%
$299.1M$177.1M

Current liabilities reduced — improved short-term financial position and working capital health.

Cash & Equivalents
Balance Sheet
+37.4%
$108.2M$148.7M

Cash position surged 37.4% — strong cash generation or capital raise providing significant financial cushion.

SG&A Expense
P&L
+35.4%
$574.4M$777.7M

SG&A up 35.4% — significant increase in sales or administrative costs, monitor impact on operating leverage.

Stockholders Equity
Balance Sheet
+18.4%
$642.6M$760.9M

Equity base grew 18.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2025-05-29
PRIOR — 2024-05-23
ADDED
Additional US tariffs or other restrictions placed on imports, retaliatory trade measures taken by other countries and resulting trade wars may have a material adverse impact on our financial condition and results of operations.
Acquisitions or investments, such as our potential acquisition of rhode, could disrupt our business and harm our financial condition.
We make the best of beauty accessible to every eye, lip and face.
We create targeted, ingredient-focused, dermatologist-developed formulas for every eye, lip and face.
We believe the combination of our passionate team of owners, value proposition, powerhouse innovation, disruptive marketing engine and productivity model has positioned us well to navigate the competitive beauty market.
+7 more — sign up free →
REMOVED
Acquisitions or investments, such as our acquisition of Naturium LLC, could disrupt our business and harm our financial condition.
We make the best of beauty accessible to every eye, lip, face and skin concern.
We create targeted, ingredient-focused, dermatologist-developed formulas for every eye, lip, face and skin concern.
We believe the combination of our value proposition, powerhouse innovation, disruptive marketing engine and our world-class team s ability to execute with quality and speed has positioned us well to navigate the competitive beauty market.
Our strategy is underpinned by four key pillars: Value Proposition .
+7 more — sign up free →
MORE OPPORTUNITY SIGNALS
IRIXHIGHIRIX demonstrated a dramatic operational turnaround with revenue surging 283% wh...
2026-04-02
CSAIHIGHCSAI underwent a dramatic financial transformation with revenue growing 271% to ...
2026-03-31
PLMKWHIGHPLMKW has entered into a definitive business combination agreement with Controll...
2026-03-31
LXEOHIGHLXEO achieved significant clinical milestones with positive interim data and reg...
2026-03-30
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →